{"id":6231,"date":"2026-06-01T12:54:39","date_gmt":"2026-06-01T09:54:39","guid":{"rendered":"https:\/\/www.clinipower.fi\/?p=6231"},"modified":"2026-06-01T12:54:39","modified_gmt":"2026-06-01T09:54:39","slug":"clinical-evidence-requirements-for-health-technology-products-in-the-eu-market","status":"publish","type":"post","link":"https:\/\/www.clinipower.fi\/en\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\/","title":{"rendered":"Clinical Evidence Requirements for Health Technology Products in the EU Market"},"content":{"rendered":"<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Clinical evidence for the EU market<\/strong> refers to scientific proof of a health technology product&#8217;s safety and efficacy in accordance with the MDR regulation. Requirements vary by device risk class and may include clinical investigations, literature reviews, or the use of existing real-world data. To obtain and maintain CE marking, manufacturers must demonstrate a sufficient level of clinical evidence \u2014 for example, to ensure patient safety.<\/p>\n<hr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\" \/>\n<h3 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">What clinical evidence does the EU MDR regulation require from health technology?<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The EU MDR regulation requires adequate clinical evidence from all medical devices according to their risk class. Clinical evidence means scientific proof demonstrating a device&#8217;s clinical benefits, safety, efficacy, and performance under real-world conditions of use.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The required level of clinical evidence varies depending on risk class and intended purpose. Generally, innovative devices or those offering new treatment modalities require their own clinical device investigation. For Class I devices, a sufficient level may potentially rely on other studies and the device&#8217;s technical safety.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Documentation requirements include a clinical evaluation plan and report, analyzing all available clinical data. The report must demonstrate the acceptability of the benefit\u2013risk ratio, and also show how the device&#8217;s clinical benefits, safety, efficacy, and performance will be monitored throughout its time on the market or over its lifecycle.<\/p>\n<hr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\" \/>\n<h3 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">When is existing clinical data sufficient for EU market access?<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Existing clinical data is sufficient when a scientifically justified equivalence to a device already on the market can be demonstrated. This requires showing technical, biological, and clinical equivalence through a detailed comparison \u2014 technical similarity alone is not enough.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Equivalence assessment principles require that the reference device has an adequate clinical history on the EU market and represents the same technological generation. The acceptability of literature reviews depends on their scope and systematic nature \u2014 marketing material alone is not sufficient as evidence.<\/p>\n<hr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\" \/>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Clinical evidence requirements for the EU market are multifaceted and depend strongly on the characteristics of the device. Choosing the right strategy saves significant time and resources in the market access process. Health technology regulation is continuously evolving, which is why expert guidance is essential to ensure successful product development.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Clinical evidence for the EU market refers to scientific proof of a health technology product&#8217;s safety and efficacy in accordance with the MDR regulation. Requirements vary by device risk class and may include clinical investigations, literature reviews, or the use of existing real-world data. To obtain and maintain CE marking, manufacturers must demonstrate a sufficient [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/www.clinipower.fi\/en\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\/\">Read More&#8230;<span class=\"screen-reader-text\"> from Clinical Evidence Requirements for Health Technology Products in the EU Market<\/span><\/a><\/p>\n","protected":false},"author":16,"featured_media":4163,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[37],"tags":[],"class_list":["post-6231","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-product-development-and-processes"],"acf":[],"gutentor_comment":0,"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Clinical Evidence Requirements for Health Technology Products in the EU Market - Clinipower Finland Oy<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.clinipower.fi\/en\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical Evidence Requirements for Health Technology Products in the EU Market - Clinipower Finland Oy\" \/>\n<meta property=\"og:description\" content=\"Clinical evidence for the EU market refers to scientific proof of a health technology product&#8217;s safety and efficacy in accordance with the MDR regulation. Requirements vary by device risk class and may include clinical investigations, literature reviews, or the use of existing real-world data. To obtain and maintain CE marking, manufacturers must demonstrate a sufficient [...]Read More... from Clinical Evidence Requirements for Health Technology Products in the EU Market\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.clinipower.fi\/en\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\/\" \/>\n<meta property=\"og:site_name\" content=\"Clinipower Finland Oy\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-01T09:54:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.clinipower.fi\/wp-content\/uploads\/2022\/04\/dccb3e2a9f815ead612fedf3619a3e55.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sylvia Syv\u00e4nen\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sylvia Syv\u00e4nen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.clinipower.fi\\\/en\\\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.clinipower.fi\\\/en\\\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\\\/\"},\"author\":{\"name\":\"Sylvia Syv\u00e4nen\",\"@id\":\"https:\\\/\\\/www.clinipower.fi\\\/en\\\/#\\\/schema\\\/person\\\/82701851d0878467369e02283af1af59\"},\"headline\":\"Clinical Evidence Requirements for Health Technology Products in the EU Market\",\"datePublished\":\"2026-06-01T09:54:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.clinipower.fi\\\/en\\\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\\\/\"},\"wordCount\":366,\"publisher\":{\"@id\":\"https:\\\/\\\/www.clinipower.fi\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.clinipower.fi\\\/en\\\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.clinipower.fi\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/dccb3e2a9f815ead612fedf3619a3e55.jpeg\",\"articleSection\":[\"Product development and processes\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.clinipower.fi\\\/en\\\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\\\/\",\"url\":\"https:\\\/\\\/www.clinipower.fi\\\/en\\\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\\\/\",\"name\":\"Clinical Evidence Requirements for Health Technology Products in the EU Market - Clinipower Finland Oy\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.clinipower.fi\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.clinipower.fi\\\/en\\\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.clinipower.fi\\\/en\\\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.clinipower.fi\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/dccb3e2a9f815ead612fedf3619a3e55.jpeg\",\"datePublished\":\"2026-06-01T09:54:39+00:00\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.clinipower.fi\\\/en\\\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.clinipower.fi\\\/en\\\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.clinipower.fi\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/dccb3e2a9f815ead612fedf3619a3e55.jpeg\",\"contentUrl\":\"https:\\\/\\\/www.clinipower.fi\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/dccb3e2a9f815ead612fedf3619a3e55.jpeg\",\"width\":1920,\"height\":1280},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.clinipower.fi\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.clinipower.fi\\\/en\\\/\",\"name\":\"Clinipower Finland Oy\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.clinipower.fi\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.clinipower.fi\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.clinipower.fi\\\/en\\\/#organization\",\"name\":\"Clinipower Oy\",\"url\":\"https:\\\/\\\/www.clinipower.fi\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.clinipower.fi\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Clinipower Oy\"},\"image\":{\"@id\":\"https:\\\/\\\/www.clinipower.fi\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.clinipower.fi\\\/en\\\/#\\\/schema\\\/person\\\/82701851d0878467369e02283af1af59\",\"name\":\"Sylvia Syv\u00e4nen\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f08683e6f46efa3950a6721f89c14d82302c8228e0358ef04fd1767ac70dae6c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f08683e6f46efa3950a6721f89c14d82302c8228e0358ef04fd1767ac70dae6c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f08683e6f46efa3950a6721f89c14d82302c8228e0358ef04fd1767ac70dae6c?s=96&d=mm&r=g\",\"caption\":\"Sylvia Syv\u00e4nen\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clinical Evidence Requirements for Health Technology Products in the EU Market - Clinipower Finland Oy","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.clinipower.fi\/en\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\/","og_locale":"en_US","og_type":"article","og_title":"Clinical Evidence Requirements for Health Technology Products in the EU Market - Clinipower Finland Oy","og_description":"Clinical evidence for the EU market refers to scientific proof of a health technology product&#8217;s safety and efficacy in accordance with the MDR regulation. Requirements vary by device risk class and may include clinical investigations, literature reviews, or the use of existing real-world data. To obtain and maintain CE marking, manufacturers must demonstrate a sufficient [...]Read More... from Clinical Evidence Requirements for Health Technology Products in the EU Market","og_url":"https:\/\/www.clinipower.fi\/en\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\/","og_site_name":"Clinipower Finland Oy","article_published_time":"2026-06-01T09:54:39+00:00","og_image":[{"width":1920,"height":1280,"url":"https:\/\/www.clinipower.fi\/wp-content\/uploads\/2022\/04\/dccb3e2a9f815ead612fedf3619a3e55.jpeg","type":"image\/jpeg"}],"author":"Sylvia Syv\u00e4nen","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Sylvia Syv\u00e4nen","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.clinipower.fi\/en\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\/#article","isPartOf":{"@id":"https:\/\/www.clinipower.fi\/en\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\/"},"author":{"name":"Sylvia Syv\u00e4nen","@id":"https:\/\/www.clinipower.fi\/en\/#\/schema\/person\/82701851d0878467369e02283af1af59"},"headline":"Clinical Evidence Requirements for Health Technology Products in the EU Market","datePublished":"2026-06-01T09:54:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.clinipower.fi\/en\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\/"},"wordCount":366,"publisher":{"@id":"https:\/\/www.clinipower.fi\/en\/#organization"},"image":{"@id":"https:\/\/www.clinipower.fi\/en\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\/#primaryimage"},"thumbnailUrl":"https:\/\/www.clinipower.fi\/wp-content\/uploads\/2022\/04\/dccb3e2a9f815ead612fedf3619a3e55.jpeg","articleSection":["Product development and processes"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.clinipower.fi\/en\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\/","url":"https:\/\/www.clinipower.fi\/en\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\/","name":"Clinical Evidence Requirements for Health Technology Products in the EU Market - Clinipower Finland Oy","isPartOf":{"@id":"https:\/\/www.clinipower.fi\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.clinipower.fi\/en\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\/#primaryimage"},"image":{"@id":"https:\/\/www.clinipower.fi\/en\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\/#primaryimage"},"thumbnailUrl":"https:\/\/www.clinipower.fi\/wp-content\/uploads\/2022\/04\/dccb3e2a9f815ead612fedf3619a3e55.jpeg","datePublished":"2026-06-01T09:54:39+00:00","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.clinipower.fi\/en\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.clinipower.fi\/en\/clinical-evidence-requirements-for-health-technology-products-in-the-eu-market\/#primaryimage","url":"https:\/\/www.clinipower.fi\/wp-content\/uploads\/2022\/04\/dccb3e2a9f815ead612fedf3619a3e55.jpeg","contentUrl":"https:\/\/www.clinipower.fi\/wp-content\/uploads\/2022\/04\/dccb3e2a9f815ead612fedf3619a3e55.jpeg","width":1920,"height":1280},{"@type":"WebSite","@id":"https:\/\/www.clinipower.fi\/en\/#website","url":"https:\/\/www.clinipower.fi\/en\/","name":"Clinipower Finland Oy","description":"","publisher":{"@id":"https:\/\/www.clinipower.fi\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.clinipower.fi\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.clinipower.fi\/en\/#organization","name":"Clinipower Oy","url":"https:\/\/www.clinipower.fi\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.clinipower.fi\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Clinipower Oy"},"image":{"@id":"https:\/\/www.clinipower.fi\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.clinipower.fi\/en\/#\/schema\/person\/82701851d0878467369e02283af1af59","name":"Sylvia Syv\u00e4nen","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f08683e6f46efa3950a6721f89c14d82302c8228e0358ef04fd1767ac70dae6c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f08683e6f46efa3950a6721f89c14d82302c8228e0358ef04fd1767ac70dae6c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f08683e6f46efa3950a6721f89c14d82302c8228e0358ef04fd1767ac70dae6c?s=96&d=mm&r=g","caption":"Sylvia Syv\u00e4nen"}}]}},"featured_image_src":"https:\/\/www.clinipower.fi\/wp-content\/uploads\/2022\/04\/dccb3e2a9f815ead612fedf3619a3e55-600x400.jpeg","featured_image_src_square":"https:\/\/www.clinipower.fi\/wp-content\/uploads\/2022\/04\/dccb3e2a9f815ead612fedf3619a3e55-600x600.jpeg","author_info":{"display_name":"Sylvia Syv\u00e4nen","author_link":"https:\/\/www.clinipower.fi\/en\/author\/sylvia\/"},"_links":{"self":[{"href":"https:\/\/www.clinipower.fi\/en\/wp-json\/wp\/v2\/posts\/6231","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.clinipower.fi\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.clinipower.fi\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.clinipower.fi\/en\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.clinipower.fi\/en\/wp-json\/wp\/v2\/comments?post=6231"}],"version-history":[{"count":1,"href":"https:\/\/www.clinipower.fi\/en\/wp-json\/wp\/v2\/posts\/6231\/revisions"}],"predecessor-version":[{"id":6232,"href":"https:\/\/www.clinipower.fi\/en\/wp-json\/wp\/v2\/posts\/6231\/revisions\/6232"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.clinipower.fi\/en\/wp-json\/wp\/v2\/media\/4163"}],"wp:attachment":[{"href":"https:\/\/www.clinipower.fi\/en\/wp-json\/wp\/v2\/media?parent=6231"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.clinipower.fi\/en\/wp-json\/wp\/v2\/categories?post=6231"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.clinipower.fi\/en\/wp-json\/wp\/v2\/tags?post=6231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}